NCT06144866View on ClinicalTrials.gov

Evaluataion of NOAC Levels in Acute Stroke

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Ischemic StrokeAnticoagulant Adverse Reaction
Interventions
DRUG

Dabigatran, rivaroxaban, apixaban, edoxaban

For patients who received direct oral anticoagulants (DOAC) before ischemic stroke or intracranial hemorrhage, the DOAC level upon hospital arrival will be measured.

Trial Locations (1)

100

RECRUITING

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER